Insider Transactions

What Aimmune Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Enright Patrick G	Director	Oct 13	Disposition to Issuer · D	−7,840	$34.50	−$270K	0
Bjerkholt Eric	Chief Financial Officer	Oct 13	Disposition to Issuer · D	−23,905	$34.50	−$825K	0
Iwicki Mark T	Director	Oct 13	Disposition to Issuer · D	−7,840	$34.50	−$270K	0
Mcdade Mark	Director	Oct 13	Disposition to Issuer · D	−7,840	$34.50	−$270K	0
Adelman Daniel C Md	Chief Medical Officer	Oct 13	Disposition to Issuer · D	−22,343	$34.50	−$771K	0
Dallas Jayson Donald Alexander	President and CEO	Oct 13	Disposition to Issuer · D	−89,250	$34.50	−$3.08M	0
Seltzer Stacey Denenberg	Director	Oct 13	Disposition to Issuer · D	−7,840	$34.50	−$270K	0
Falberg Kathryn E	Director	Oct 13	Disposition to Issuer · D	−7,840	$34.50	−$270K	0
Haumann Brett K	Director	Oct 13	Disposition to Issuer · D	−13,313	$34.50	−$459K	0
Sheehy Douglas T.	See Remarks	Oct 13	Disposition to Issuer · D	−36,875	$34.50	−$1.27M	0
Behar Gregory	Director	Oct 13	Disposition to Issuer · D	−7,840	$34.50	−$270K	0
Behar Gregory	Director	Oct 13	Other Transaction · J	−10,192	—	—	0
Oxtoby Andrew	Chief Commercial Officer	Oct 13	Disposition to Issuer · D	−20,250	$34.50	−$699K	0
Societe des Produits Nestle S.a.	10% owner	Oct 13	Open-market buy · P	+10,681,704	$34.50	+$369M	23,408,817
Societe des Produits Nestle S.a.	10% owner	Oct 13	Open-market buy · P	+43,435,583	$34.50	+$1.5B	43,435,583
Enright Patrick G	Director	Oct 10	Tender Offer · U	−91,697	$34.50	−$3.16M	0
Enright Patrick G	Director	Oct 10	Tender Offer · U	−70,561	$34.50	−$2.43M	0
Bjerkholt Eric	Chief Financial Officer	Oct 10	Tender Offer · U	−27,805	$34.50	−$959K	0
Iwicki Mark T	Director	Oct 10	Tender Offer · U	−39,567	$34.50	−$1.37M	0
Mcdade Mark	Director	Oct 10	Tender Offer · U	−26,852	$34.50	−$926K	0

Page 1 of 17 · showing the 20 most recent Sign up free to view all 326 transactions and filter by insider →

Comments